[go: up one dir, main page]

AR033808A1 - Una composicion topica de anestesia local y los parches y los envases que la contienen - Google Patents

Una composicion topica de anestesia local y los parches y los envases que la contienen

Info

Publication number
AR033808A1
AR033808A1 ARP010101125A ARP010101125A AR033808A1 AR 033808 A1 AR033808 A1 AR 033808A1 AR P010101125 A ARP010101125 A AR P010101125A AR P010101125 A ARP010101125 A AR P010101125A AR 033808 A1 AR033808 A1 AR 033808A1
Authority
AR
Argentina
Prior art keywords
patches
topical composition
containers containing
local anesthesia
composition
Prior art date
Application number
ARP010101125A
Other languages
English (en)
Original Assignee
Epicept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicept Inc filed Critical Epicept Inc
Publication of AR033808A1 publication Critical patent/AR033808A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Método no invasivo y no sistémico para administrar un anestésico local. El método comprende la aplicación tópica de un anestésico local en combinación con un agente de penetración intradermal seleccionado del grupo que consiste en una composición de aloe, un triglicérido y una mezcla de los mismos. Composición tópica que comprende un anestésico local, o una de sus sales farmacéuticamente aceptables, y un agente de penetración intradermal elegido entre un triglicérido, una composición de aloe y sus mezclas. Parches y envases que contienen dicha composición de uso tópico.
ARP010101125A 2000-03-10 2001-03-09 Una composicion topica de anestesia local y los parches y los envases que la contienen AR033808A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/523,652 US6455066B1 (en) 2000-03-10 2000-03-10 Intradermal-penetration agents for topical local anesthetic administration

Publications (1)

Publication Number Publication Date
AR033808A1 true AR033808A1 (es) 2004-01-07

Family

ID=24085856

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101125A AR033808A1 (es) 2000-03-10 2001-03-09 Una composicion topica de anestesia local y los parches y los envases que la contienen

Country Status (18)

Country Link
US (2) US6455066B1 (es)
EP (1) EP1313456A2 (es)
JP (1) JP2003526678A (es)
KR (1) KR100764156B1 (es)
AR (1) AR033808A1 (es)
AU (2) AU4544901A (es)
BR (1) BR0109150A (es)
CA (1) CA2402296A1 (es)
CZ (1) CZ20023030A3 (es)
HU (1) HUP0300472A3 (es)
IL (2) IL151671A0 (es)
MX (1) MXPA02008828A (es)
NO (1) NO20024309L (es)
NZ (1) NZ521470A (es)
PL (1) PL203847B1 (es)
RU (1) RU2002126999A (es)
SK (1) SK12962002A3 (es)
WO (1) WO2001068138A2 (es)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US7018647B1 (en) * 1999-12-27 2006-03-28 Teikoku Seiyaku Co., Ltd Patches for external use
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
DE10025890A1 (de) * 2000-05-25 2001-11-29 Euro Celtique Sa Dosierung von transdermalen Arzneimittelsystemen
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US6500408B2 (en) 2001-01-27 2002-12-31 Jc Technologies, Inc. Enamel-safe tooth bleach and method for use
US6777000B2 (en) 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
RU2708563C2 (ru) * 2001-03-16 2019-12-10 Алза Корпорейшн Трансдермальный пластырь для введения фентанила
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine
DE10158199A1 (de) * 2001-11-27 2003-06-18 Beiersdorf Ag Juckreizstillende kosmetische und dermatologische Zubereitungen
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
DK1480625T3 (da) * 2002-03-06 2008-10-27 Hexal Ag Transdermalt system med fentanyl
US20040202704A1 (en) * 2002-08-30 2004-10-14 Watson Pharmaceuticals, Inc. Transdermal delivery systems and methods
DE10251256A1 (de) * 2002-11-04 2004-05-13 Novosis Ag Transdermales Wirkstoffabgabesystem für Oxybutynin
BRPI0408454A (pt) * 2003-03-21 2006-04-04 Nexmed Holdings Inc composição tópica, método de tratar a ejaculação precoce, e, uso da composição
US20050042267A1 (en) * 2003-08-20 2005-02-24 Kimberly-Clark Worldwide, Inc. System for providing therapy to a portion of a body
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
AU2005249274B2 (en) * 2004-06-04 2011-02-24 Camurus Ab Liquid depot formulations
US20070196293A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for treating photo damaged skin
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20070189978A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for dermally treating musculoskeletal pain
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US20080019927A1 (en) * 2004-06-07 2008-01-24 Jie Zhang Compositions and methods for dermally treating neuropathy with minoxidil
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
US20070196323A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070189980A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for treating alopecia
US20060029654A1 (en) * 2004-08-04 2006-02-09 Cassel R D Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
ES2429040T5 (es) * 2004-08-31 2017-06-13 Stiefel Research Australia Pty Ltd Método y composiciones de microemulsión y emulsión submicrónica
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US7718674B2 (en) * 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20060223788A1 (en) * 2005-03-29 2006-10-05 Cathcart Clifton H Analgesic composition for topical use
EP1874282B1 (en) 2005-04-06 2010-09-15 Adamas Pharmaceuticals, Inc. Methods and compositions for treatment of cns disorders
US9017717B2 (en) * 2006-01-16 2015-04-28 Peach Technologies Llc Bandage for facilitating transdermal respiration and healing
US7582609B2 (en) * 2006-03-01 2009-09-01 Digna Biotech, S.L. Method for the treatment of skin fibrosis and suitable compositions for such treatment
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
CA2664215A1 (en) * 2006-09-21 2008-03-27 Coastal Solutions, Inc. Compositions and methods for treating jellyfish stings
DE102006048130A1 (de) * 2006-10-06 2008-04-10 Axxonis Pharma Ag Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
US7976951B2 (en) 2006-11-14 2011-07-12 Momentive Performance Materials Inc. Laminate containing an adhesive-forming composition
US7829116B2 (en) 2006-11-14 2010-11-09 Momentive Performance Materials Inc. Adhesive-forming composition and blend of adhesives obtained therefrom
US20100041704A1 (en) * 2007-01-12 2010-02-18 Aberg A K Gunnar Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
WO2008133982A2 (en) * 2007-04-27 2008-11-06 Lectec Corporation Adhesive patch with aversive agent
KR101583680B1 (ko) * 2007-10-15 2016-01-08 알자 코퍼레이션 펜타닐의 1일-1회 교체 경피 투여
US8658699B2 (en) * 2008-05-19 2014-02-25 Massachusetts Institute Of Technology Chemical permeation enhancers enhance nerve blockade by toxins
US8142592B2 (en) 2008-10-02 2012-03-27 Mylan Inc. Method for making a multilayer adhesive laminate
KR20110082142A (ko) 2008-10-06 2011-07-18 밀란 테크놀로지즈 인코포레이티드 비정질 로티고틴 경피 시스템
US8679470B2 (en) 2008-11-28 2014-03-25 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
DE102009008851A1 (de) 2009-02-13 2010-08-19 Amw Gmbh Transdermales System mit Immunmodulator
DE102010048788A1 (de) 2009-02-13 2011-05-19 Amw Gmbh Transdermales System mit Immunmodulator
DE102010046464A1 (de) 2009-03-19 2011-04-21 Amw Gmbh Transdermales System mit Aromatasehemmer
US8957207B2 (en) 2009-03-24 2015-02-17 Proteus S.A. Methods for producing phycotoxins
JP5634679B2 (ja) * 2009-03-24 2014-12-03 リンテック株式会社 局所麻酔貼付剤
WO2010114973A1 (en) * 2009-04-01 2010-10-07 Jie Zhang Methods for treating myofascial, muscle, and/or back pain
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
EP2427160A4 (en) * 2009-05-04 2012-12-19 Zars Pharma Inc METHOD FOR TREATING PAIN RELATED TO NEUROMAS, NERVE CLAIMS AND OTHER SUFFERING PAINS
AU2010279384A1 (en) 2009-08-05 2012-03-01 Wake Forest University Compositions and methods for inducing apoptosis in prostate cancer cells
US8778387B2 (en) * 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
US8247390B2 (en) * 2009-09-28 2012-08-21 Luromed Llc Modified hydrophilic polymers containing hydrophobic groups
US8741343B2 (en) 2009-12-02 2014-06-03 Adamas Pharmaceuticals, Inc. Method of administering amantadine prior to a sleep period
AU2011207398B2 (en) 2010-01-22 2014-11-20 Hyprotek, Inc. Antimicrobial agent comprising peroxide, alcohol and chelating agent
DE102010026879A1 (de) 2010-02-11 2011-08-11 AMW GmbH, 83627 Transdermales System mit Immunmodulator
DE102010026883A1 (de) 2010-03-11 2011-12-15 Amw Gmbh Transdermales System mit Aromatasehemmer
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
CN103338771B (zh) * 2011-02-02 2016-04-06 日东电工株式会社 贴剂
CA2826217A1 (en) * 2011-02-02 2012-08-09 Dainippon Sumitomo Pharma Co., Ltd. Transdermal patch
US8512768B2 (en) 2011-02-23 2013-08-20 Miss Smarty Pants Enterprises, Inc. Pain relieving composition
US8293288B2 (en) 2011-02-23 2012-10-23 Edna Ma Pain relieving composition
EP2683359B1 (en) * 2011-03-07 2015-04-22 3M Innovative Properties Company Microneedle devices and methods
EP2708229B1 (en) 2011-05-10 2019-07-31 Itochu Chemical Frontier Corporation Non-aqueous patch
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
WO2013046335A1 (ja) 2011-09-27 2013-04-04 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
US9039967B2 (en) 2012-02-06 2015-05-26 Hyprotek, Inc. Antiseptic applicators and packaging techniques
CA2879942C (en) 2012-07-26 2020-06-02 Camurus Ab Opioid formulations
EA034855B1 (ru) 2012-07-26 2020-03-30 Камурус Аб Предшественник депо-препарата, содержащий бупренорфин, и способ лечения путем его введения
WO2014123100A1 (ja) * 2013-02-05 2014-08-14 リンテック株式会社 貼付型表面麻酔剤
KR20210062693A (ko) 2013-03-15 2021-05-31 더 칠드런스 메디칼 센터 코포레이션 지속성 국소 마취용 네오삭시톡신 조합 제형
HK1220109A1 (zh) * 2013-03-15 2017-04-28 Nal Pharmaceutical Group Limited 含卡巴拉汀的经皮给药系统
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
RU2737464C2 (ru) 2015-12-30 2020-11-30 Кориум Интернэшнл, Инк. Системы и способы длительного трансдермального введения
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
CA3032044A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Donepezil transdermal delivery system
CA3032103A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Memantine transdermal delivery systems
WO2018022814A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
CA3086163A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
WO2019194871A1 (en) * 2018-04-05 2019-10-10 Erbst Steven Robert Therapeutic elastic bandage for modulating the endocannabinoid system
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法
US11481438B2 (en) * 2020-05-26 2022-10-25 Hulu, LLC Watch sequence modeling for recommendation ranking
CN112438963A (zh) * 2020-11-11 2021-03-05 长沙晶易医药科技有限公司 一种利多卡因-丙胺卡因药物组合物的外用制剂及其应用
US20220331479A1 (en) * 2021-03-29 2022-10-20 Remy Biosciences, Inc. Topical pain patch

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US720962A (en) * 1900-07-07 1903-02-17 Casimir Pauthonier Incandescent electric lamp.
US3892853A (en) 1967-05-22 1975-07-01 Aloe 99 & 0 Inc Stabilized aloe vera gel and preparation of same
US3814095A (en) 1972-03-24 1974-06-04 H Lubens Occlusively applied anesthetic patch
DE2823174A1 (de) 1977-07-06 1979-01-25 Astra Laekemedel Ab Arzneimittel fuer die prophylaktische behandlung postoperativer tiefer venenthrombose
US4748022A (en) 1985-03-25 1988-05-31 Busciglio John A Topical composition
DE3522060A1 (de) 1985-06-20 1987-01-08 Liedtke Pharmed Gmbh Arzneipflaster fuer systemische anwendungen
US5272139A (en) 1986-08-27 1993-12-21 Cary George R Jr Amelioration or elimination of postoperative pain
US4917688A (en) 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
US5002974A (en) * 1988-04-04 1991-03-26 Warner-Lambert Co. Anesthetic/skin moisturizing composition and method of preparing same
US5279837A (en) * 1988-10-14 1994-01-18 Hill Richard J Styptic composition
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
DE3919982A1 (de) 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
US5417671A (en) 1990-05-23 1995-05-23 Jackson; Richard R. Medical devices having local anesthetic effect and methods of their manufacture
US5332576A (en) 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
US5229130A (en) 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US5356811A (en) * 1992-04-21 1994-10-18 Coats Billy C Method of processing stabilized aloe vera gel obtained from the whole aloe vera leaf
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5330452A (en) 1993-06-01 1994-07-19 Zook Gerald P Topical medicating device
US5415866A (en) 1993-07-12 1995-05-16 Zook; Gerald P. Topical drug delivery system
US5466465A (en) 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
DE4416927C1 (de) 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
JP4124495B2 (ja) * 1995-03-22 2008-07-23 天藤製薬株式会社 局所麻酔組成物
DE19524691A1 (de) 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526019A1 (de) 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
DE19526031A1 (de) 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Rückenschmerz und Muskelverspannung
US5658583A (en) 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US5720962A (en) 1995-10-04 1998-02-24 Au Pharmaceuticals, Inc. Analgesic lotion for hemorrhoids and method of making such lotion
CA2256365A1 (en) 1996-05-22 1997-11-27 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
JPH101441A (ja) * 1996-06-14 1998-01-06 Tendou Seiyaku Kk 局所麻酔組成物
US6210705B1 (en) 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
US5955112A (en) 1998-02-11 1999-09-21 Kaplan; Jeffrey Non-stinging styptic pencil
US6120792A (en) 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
ES2198196B2 (es) * 1998-07-16 2006-04-01 Memorial Sloan-Kettering Cancer Center Composiciones topicas que comprenden un analgesico opioide y un antagonista de nmda.
CN1188176C (zh) * 1998-11-24 2005-02-09 强生消费者公司 用于敷料和绷带上起施用活性成分作用的涂层
AU4842100A (en) 1999-12-10 2001-06-18 Teri Buseman Anti pruritic patch
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration

Also Published As

Publication number Publication date
CA2402296A1 (en) 2001-09-20
US20030138505A1 (en) 2003-07-24
HUP0300472A3 (en) 2006-07-28
US6455066B1 (en) 2002-09-24
KR100764156B1 (ko) 2007-10-08
PL357944A1 (en) 2004-08-09
KR20030009385A (ko) 2003-01-29
IL151671A (en) 2010-02-17
AU2001245449B2 (en) 2007-03-22
PL203847B1 (pl) 2009-11-30
RU2002126999A (ru) 2004-03-10
JP2003526678A (ja) 2003-09-09
MXPA02008828A (es) 2004-10-15
CZ20023030A3 (cs) 2003-06-18
NO20024309D0 (no) 2002-09-09
AU4544901A (en) 2001-09-24
US6746689B2 (en) 2004-06-08
NO20024309L (no) 2002-10-03
EP1313456A2 (en) 2003-05-28
IL151671A0 (en) 2003-04-10
WO2001068138A3 (en) 2002-01-17
SK12962002A3 (sk) 2003-06-03
WO2001068138A2 (en) 2001-09-20
NZ521470A (en) 2004-07-30
BR0109150A (pt) 2003-04-22
HUP0300472A2 (hu) 2003-09-29

Similar Documents

Publication Publication Date Title
AR033808A1 (es) Una composicion topica de anestesia local y los parches y los envases que la contienen
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ES2173978T3 (es) Utilizacion de un alcohol graso insaturado.
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
AR023806A1 (es) Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas
MX2025004156A (es) Composiciones topicas para el alivio del dolor.
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
MXPA01003182A (es) Sistema de liberacion controlada de agentes antifungicos y queratoliticos para el tratamiento local de las infecciones fungicas de la una y los tejidos circundantes.
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ES2113444T3 (es) Medicamentos.
BR9913154A (pt) Composição de musse
DE60129849D1 (de) Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
SV2002000969A (es) Composicion parenteral reconstituible
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
AR034150A1 (es) Empleo de exemestano y producto que contiene exemestano
MXPA03000276A (es) Nueva formulacion en aerosol que contiene una molecula fluorada polar.
AR017222A1 (es) Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos

Legal Events

Date Code Title Description
FB Suspension of granting procedure